Aarhus University logo

    • About
      • About the Nordic EMBL Partnership
      • Mission statement
      • EMBL non-tenure model
      • Contact
    • News
    • Collaborations
      • NORPOD - Postdoctoral Researcher Programme
      • NordForsk: Nordic EMBL Partnership Hub
      • How the Nordic EMBL Partnership is helping to fight COVID-19
      • Tools of the Trade Data Science Webinar Series
      • Nordic EMBL Partnership Meetings
      • Nordic EMBL Partnership Science and Art
    • Research
    • Technologies
    • Training
    • Careers
    • Internal

    Read more

    Click here to read more

    DANDRITE

    The Danish Research Institute of Translational Neuroscience (DANDRITE) is the Danish node of the Nordic EMBL Partnership, and performs basic and translational research in brain and the nervous system.

    FIMM

    The Institute for Molecular Medicine Finland (FIMM) is the Finnish node of the Nordic EMBL Partnership. FIMM’s research interests are human genomics and personalized medicine, with a focus on translational research.

    MIMS

    The Laboratory for Molecular Infection Medicine Sweden (MIMS) is the Swedish node of the Nordic EMBL Partnership. MIMS aims to strengthen Swedish research and enhance the dynamics in the field of molecular medicine.

    NCMBM

    The Norwegian Centre for Molecular Biosciences and Medicine (NCMBM) is the Norwegian node of the Nordic EMBL Partnership. NCMBM conducts molecular medicine & biotech research and works to translate these findings into clinical practice. 

    News from the Partnership


    FIM­M­POD pro­gramme pro­motes in­dustry-aca­de­mia part­ner­ships through joint postdoc po­s­i­tions

    30 August 2021 - People

    The second FIMM-Bayer joint postdoctoral researcher has been recruited as part of the FIMMPOD professional development programme activities.…

    New dia­gnostic as­say holds po­ten­tial for tail­or­ing personalized cancer treat­ment

    18 August 2021 - Research news

    Researchers at FIMM/University of Helsinki show that cells that are freshly isolated from lung cancers can be used to create robust drug response…

    Increased risk of acute myocardial infarction and stroke following COVID-19

    17 August 2021 - Research news

    Publication from MIMS Clinical Research Fellow, Anne-Marie Fors Connolly, concludes that the risk of acute myocardial infarction and stroke is…

    Large ge­n­omic analysis high­lights COVID-19 risk factors

    11 August 2021 - Research news

    Findings from an international collaboration, initiated at FIMM, uncovers several genetic markers associated with SARS-CoV-2 infection and COVID-19…

    Page 47 of 70.

    • Previous
    • 1
    • …
    • 46
    • 47
    • 48
    • …
    • 70
    • Next

    Upcoming Partnership Events


    No events found.

    Follow us!

    Follow us for the latest updates and insights! Join our community and stay connected with us on the following platforms

    LinkedIn
    Bluesky
    X

     

    About 

    News 

    Collaborations

    Research

    Technologies

    Training

    Careers

     

     

     

    Follow us

    X: @NordicEMBL

    LinkedIn: linkedin.com/company/nordic-embl-partnership-for-molecular-medicine

     

    The Nordic EMBL Partnership for Molecular Medicine combines the complementary research expertise of the Nordic countries with a common aim to address some of the biggest challenges in biomedicine today.

     

    Revised 21.03.2025

    © — Cookies at au.dk
    Privacy Policy
    Accessibility Statement

    15450 / i43